IV. Circumcision & Bodily Autonomy
Circumcision and HIV: The African Trials in Context
The HIV benefit is for consenting adults in high-prevalence epidemics, not American babies.
Three large African trials found that adult circumcision cut female-to-male HIV transmission, and the WHO recommends it for adult men in high-prevalence regions. That is a real finding. It does not justify circumcising infants in a low-prevalence country like the US.
The strongest medical argument for circumcision comes from three randomized trials in South Africa, Kenya, and Uganda, published between 2005 and 2007. They found that voluntary adult male circumcision reduced female-to-male HIV transmission by roughly 50 to 60 percent. On that basis the WHO and UNAIDS recommend circumcision as one HIV tool for adult men in regions with high, mostly heterosexual epidemics. This is genuine and worth stating plainly.
It also does not transfer to an American maternity ward. The trials studied adults who chose the procedure, in countries where HIV spreads largely through heterosexual sex and prevalence is high. The United States is a low-prevalence country where HIV spreads through different routes, and condoms outperform circumcision at a fraction of the cost and none of the tissue. A boy who wants this protection can choose it as an adult, with anesthesia and consent. Researchers including Boyle and Hill have laid out these limits in detail.
50-60%
HIV reduction, adult men in the trials
Adults
Who chose the procedure themselves
High-prevalence
Settings where the benefit was measured
Condoms
More effective, and remove nothing
Why it matters
A real benefit for a consenting adult in Johannesburg is not a reason to cut a newborn in Ohio who can simply decide for himself in twenty years.
This is one finding from the research library behind How to Birth a Mother. Everything here traces back to a study, a dataset, or a systematic review.